Kazia Therapeutics (KZIA) Exchange Rate Effect (2016 - 2021)
Kazia Therapeutics (KZIA) posted Exchange Rate Effect of $436897.2 for Q4 2021, up 134.15% on a QoQ basis from -$1.3 million in Q4 2020, and up 134.15% year-over-year from $186591.3 in Q4 2020.
Kazia Therapeutics (KZIA) Exchange Rate Effect (2016 - 2021) Analysis & Trends
Kazia Therapeutics' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at $436897.2 for Q4 2021.
- Quarterly Exchange Rate Effect rose 134.15% year-over-year to $436897.2 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $15917.2 (down 95.75% YoY) and the FY2025 annual result came in at -$10246.9, down 229.57% from the prior year.
- Exchange Rate Effect was $436897.2 for Q4 2021 at Kazia Therapeutics, up from -$1.3 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $436897.2 in Q4 2021 and bottomed at -$1.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 436,897.19 |
| Dec 31, 2021 | 436,897.19 |
| Dec 31, 2020 | -1.28 Mn |
| Dec 31, 2020 | -1.28 Mn |
| Dec 31, 2016 | -26,505.35 |
| Dec 31, 2016 | -26,505.35 |